The haematological malignancies patient report outcomes (HM-PRO) measure has been developed to support patients and their clinicians in discussing, addressing and better recording quality of life issues that matter patients.
Common Terminology Criteria for Adverse Events (CTCAE) is widely accepted as the standard classification and severity grading scale for adverse events in cancer therapy, clinical trials and other oncology settings. Version 5.0 is the most updated document (November 27, 2017)
MyPOS is a myeloma-specific version of the Palliative care Outcome Scale recently developed and validated to measure myeloma-specific quality of life issues and intended for use in clinical care. Click here to register and view
The Lawton Instrumental Activities of Daily Living (IADL) scale assesses the more complex activities of daily living necessary for living in the community, such as shopping, cooking and managing finances. These skills are usually lost before other activities of daily living functions are, such as bathing, dressing and eating.
The Eastern Cooperative Oncology Group (ECOG) performance status is a scale used to assess how a patient’s disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis.